INTRODUCTION
The advances in science and technology have increased our knowledge and understanding of the pathogenesis toward periodontal diseases. Periodontal diseases are basically infectious diseases, but environmental, physical, social, and host factors may affect and modify the disease expression. Chronic periodontitis, being the most prevalent form of periodontitis, can be clinically diagnosed by the detection of chronic inflammatory changes in the marginal gingiva, presence of periodontal pockets, loss of clinical attachment, and radiographically by observation of bone loss. 1 Therefore, a two-way relationship exists in which the periodontal disease of an individual may have an effect on an individual's systemic health or the systemic disease may influence an individual's periodontal status.
Considerable scientific data indicate that the localized infections that are characteristic of chronic periodontitis can have a significant effect on the systemic health of humans and animals. [2] [3] [4] [5] With the periodontal tissues initiating an inflammatory response to bacteria and their products, systemic challenges with these agents also evoke a major vascular response or better termed as the host response. Infections, malignant cells, and autoimmune dysregulation all provoke the activation of the immune system and production of cytokines, especially tumor necrosis factor (TNF)-α and interleukin (IL)-1 and IL-6. 6 These inflammatory cytokines can depress erythropoietin production leading to the development of anemia. 7, 8 The anemia of chronic disease (ACD)is defined as the anemia that occurs in chronic infections,inflammatory conditions or neoplastic disorders that is not due to marrow deficiencies or other diseases and occurs despite the presence of adequate iron stores and vitamins. 9 Hutter et al 10 suggested that periodontitis needs to be considered as a chronic disease that may cause a decrease in the number of erythrocytes and consequently lower hemoglobin concentrations (Hb%) in a substantial number of patients. The most prominent characteristic of anemia of chronic disease (ACD) is the development of disturbances of iron homeostasis with increased uptake and retention of iron within the cells of the reticuloendothelial system. A small attempt, however, is required to know whether treating periodontal disease locally will have an effect on systemic conditions. Thus, the present study was taken up to evaluate the effect of periodontal therapy on hematological parameters on subjects with chronic generalized periodontitis.
MATERIALS AND METHODS
The present study was done as a 12-month follow-up (longitudinal cohort study) comprising 42 adult male subjects (aged 30-55 years) with chronic generalized periodontitis, who were voluntarily recruited from the outpatient section of the Department of Periodontics, Faculty of Dental Sciences, Institute of Medical Sciences (IMS), Benares Hindu University. Subjects with chronic periodontitis were screened until a final sample size of 42 was achieved, who fulfilled the inclusion criteria of having pocket probing depth (PPD) ≥ 5 mm at 30% of sites and CAL ≥ 2 mm at 30% of sites. 1 Systemic and family history were recorded in detail. Subjects suffering from any (1) acute or chronic medical conditions, except chronic periodontitis, (2) subjects having a history of blood loss, (3) present or past smokers, (3) subjects who have undergone periodontal therapy, (4) subjects who have used antibiotics or oral supplementation in the previous 6 months prior to enrollment, and (5) subjects having less than 16 remaining teeth in the mouth were excluded.
The research protocol was submitted to the Institutional Ethical Committee of IMS. After ethical approval, all subjects were verbally informed about the Study Protocol, and a written informed consent was obtained.
Study Flow Chart
At the first visit, an informed verbal/written consent was taken from the subjects and signs of inflammation were recorded using PI and GI. The PPD and CAL were recorded using the World Health Organization probe. After recording the periodontal status, blood samples were obtained from all patients for hematological investigations. The patients were treated as per routine periodontal therapy and followed for a period of 12 months. Patients were neither put on any iron or vitamin supplements nor any modifications in the diet introduced. Periodontal parameters were again recorded after 6 months and 1 year; however, hematological investigations were repeated at the end of 1 year only (Flow Chart 1).
All the examinations were carried out by a single skilled dental professional. Intraexaminer reliability was 0.81 for PI, 0.83 for GI, 0.79 for PPD, and 0.82 for CAL.
Red Blood Cells Analyses
Under aseptic measures, 5 mL of venous blood sample was drawn by venipuncture from antecubital fossa between 9:00 am and 12:00 noon using a 5 mL syringe. The collected sample was divided into two parts, the first one for hematological parameter analysis and the second one for serum ferritin estimation. Samples collected were immediately transported to the laboratory for analysis of Hb%, number of erythrocytes, MCV, MCH, and MCHC. The samples were analyzed on a fully automated hematologic analyzer. The ESR was measured according to Wintrobe's method. Serum ferritin estimation was done in Mindray BS-800 analyzer. Only patients with serum ferritin value above 30 ng/mL were included in the present study in order to exclude patients with pure iron deficiency anemia.
Statistical Analyses
The collected data were subjected to statistical analysis through Statistical Package for the Social Sciences (statistical presentation system software). The statistical methods applied were paired t test, repeated measures analysis of variance (ANOVA), and descriptive statistics. The paired sample t test procedure was used to compare the means of variables with two readings. Repeated measures ANOVA procedure was used for the parameters having more than two readings. The results were presented in text, tables, and graphs.
RESULTS
Statistical evaluation of clinical and hematological parameters gave the following results. Table 1 and Graphs 1 to 5 show the mean, standard deviation, repeated measures ANOVA of PI scores, GI score, PPD score, and CAL score at baseline, 6 months, and 1 year and the result was found highly significant statistically.
The mean plaque score was 1.74, 1.00, 0.84 at baseline, 6 months, and 1 year follow-up respectively. When repeated measures ANOVA was applied, there was statistically significant difference in plaque scores. Least plaque score was seen at 1 year follow-up followed by 6 months [p < 0.000, highly significant (HS)]. Table 1 The mean gingival score was 1.75, 1.08, 0.82 at baseline, 6 months, and 1 year follow-up respectively. When repeated measures ANOVA was applied, there was statistically significant difference in GI scores. Least gingival score was seen at 1 year follow-up followed by 6 months (p < 0.000, HS).
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The mean PPD score was 5.2, 3.77, 2.7 at baseline, 6 months, and 1 year follow-up respectively. When repeated measures ANOVA was applied, there was statistically significant difference in plaque scores. Least plaque score was seen at 1 year follow-up followed by 6 months (p < 0.000, HS).
The mean CAL score was 2.5, 2.15, and 1.20 at baseline, 6 months, and 1 year follow-up respectively. When repeated measures ANOVA was applied, there was statistically significant difference in CAL scores. Least CAL score was seen at 1 year follow-up followed by 6 months (p < 0.000, HS).
The All parameters of blood analyses showed improvement over 1 year. The difference was statistically significant for all the parameters except MCV, which showed no statistical differences from baseline to 1 year (Table 2 , Graphs 6 and 7).
DISCUSSION
The purpose of the present interventional study was to evaluate the hematologic status of patients with chronic periodontitis and assess the effect of periodontal therapy on hematological parameters. Only patients with serum ferritin above 30 ng/mL were included in the study. This was done to exclude patients with pure iron deficiency anemia. 10 Smokers were excluded because smoking is considered a cofactor for the development of periodontitis [11] [12] [13] and anemia. 14 Women were excluded from the study due to failure to adjust to menopausal status and blood loss due to menstrual cycle. Previous studies have reported a tendency toward anemia in patients with chronic periodontitis, 15-19 whereas a reverse relationship was presented in the data collected during the third national health and nutrition examination survey (NHANES III), which proposed that individuals with anemia may be more likely to have periodontal disease. 20 Few studies failed to show any association between Hb level and periodontal status. 21, 22 Chronic periodontitis subjects with no history of systemic disease and reduced Hb and erythrocyte counts suggest that chronic periodontitis should be considered as a possible cause or contributing factor for ACD. For any inflammatory condition, ESR is considered an important parameter. In our study, increased values of ESR at baseline suggests that chronic periodontitis has an inflammatory component in it and decrease in ESR values after periodontal treatment shows reduction of periodontal inflammation. 10 In chronic periodontitis subjects, reduced level of Hb and erythrocyte is thought to be caused by upregulation of the proinflammmatory cytokine. Proinflammatory cytokines, such as TNF-α, IL-1β, interferon γ, and prostaglandin E2 are found in high concentrations in inflamed periodontal tissues. The various cytokines can enter the blood circulation and affect distant sites and organs. 1 The same inflammatory cytokines have been found to be central in the pathogenesis of ACD. 10 It has been suggested that hepcidin is a primary factor in the pathogenesis of ACD, which is a cytokine-mediated anemia commonly faced in clinical practice and characterized by hypoferremia with adequate reticuloendothelial iron stores. 23 A previous study 24 indicated that IL-6 mediates hepcidin increases, resulting in hypoferrremia during inflammation. Kemna et al 25 showed the importance of the IL-6-hepcidin axis in the development of hypoferremia in inflammation and focused on the rapid responsiveness of this iron regulatory system. Our study exhibits a change in mean Hb value by 1.24 mg/dL (p < 0.001) and a mean increase of 0.37 million/ 28 The present study shows statistically highly significant change in Hb and RBC values, but not as high as seen in anemia due to other systemic inflammatory conditions like rheumatoid arthritis 29 and multiple myeloma, 30 hence concluding that anemia due to chronic periodontitis is mild. The present study shows improvement in all hematologic parameters in subjects with chronic generalized periodontitis from baseline to 12 months. These can be interpreted on the supposition that as time progresses, further reductions in periodontal inflammation lead to improvement in hematologic parameters 19 ; hence, the resolution of periodontal inflammation with improvement in hematologic parameters provides evidence that periodontal therapy can improve the anemic status of subjects with chronic periodontitis.
CONCLUSION
Chronic systemic conditions have a direct effect on the general health and well-being of an individual. The present study suggests that chronic periodontitis may cause reduction of Hb concentration and RBC count and provides evidence that periodontal therapy improved the hematologic status of subjects with chronic periodontitis. The present study also strengthens the evidence that periodontitis does have various systemic effects. However, considering the limited sample size and lack of evaluation of the relationship between severity of periodontitis and anemia in the present study, future studies remain to be conducted, which will further reduce the bias occurring due to other confounding factors as well as provide a better and more thorough view of the real situation.
